Back to results
US 2023/0121346 A1Published application
The salts of a compound and the crystalline forms thereof
AssigneeHutchison Medipharma Limited
InventorsWenji LI, Ling FENG
Life of this patent
Estimating the term…
Abstract
The present invention relates to the salts of a compound and the crystalline forms thereof. More specifically, the present invention belongs to the pharmaceutical field, and provides the pharmaceutically acceptable salts of the compound 4-chloro-3-(2-(2-((4-((3S,5R)-3,5-dimethylpiperazin-1-yl)phenyl)amino)pyrimidin-5-yl)ethyl)-5-methoxy-N- methylbenzamide and the crystalline forms thereof, the pharmaceutical compositions comprising the same as well as the methods for preparing the same and the use thereof.
Claims51
A salt of Formula A:
- wherein n is 0.5 or 1;
- and M is a pharmaceutically acceptable acid.
Dependencies are inferred from the claim text.